Current location - Plastic Surgery and Aesthetics Network - Plastic surgery and medical aesthetics - Why did Enterprise A fail to promote new anti-hepatitis B drugs in Xiaogan, Hubei Province by adopting the "old three samples"?
Why did Enterprise A fail to promote new anti-hepatitis B drugs in Xiaogan, Hubei Province by adopting the "old three samples"?
1, first of all, the economic affordability is limited.

2. Secondly, people's understanding of the seriousness of the disease and its cognitive level are limited.

Finally, people pay attention to the key value of products, not the formal value of products such as appearance packaging, but the consumption efficiency. These are the reasons why Enterprise A failed to promote new anti-hepatitis B drugs in Xiaogan, Hubei Province by adopting the "old three samples".